Hormone Therapy for Menopause: Risks Re-evaluated, Hope Renewed

The Hankyoreh reports on a significant development for women's health in South Korea, highlighting the recent re-evaluation of hormone replacement therapy (HRT) and the FDA's decision to remove its strongest warnings regarding breast cancer and cardiovascular disease. This news offers a much-needed clarification for countless Korean women who have harbored anxieties about HRT, often fueled by sensationalized media reports of past studies like the Women's Health Initiative (WHI).

For decades, the narrative surrounding HRT in South Korea, as in many parts of the world, has been dominated by fear. The potential risks, particularly breast cancer, were amplified, leading many women to suffer through severe menopausal symptoms without seeking treatment. This article underscores that such fears were often based on a misinterpretation or exaggeration of data, particularly concerning older participants in the WHI study whose health profiles differed significantly from women initiating HRT closer to menopause.

The Korean medical community, represented by figures like Professor Kim Mi-ran of Seoul St. Mary's Hospital and honorary president of the Korean Society of Menopause, welcomes this news as a 'ray of hope.' The emphasis is now shifting towards the benefits of early intervention. The article stresses that the period within 10 years of menopause or before the age of 60 is a critical 'golden time' for managing menopausal symptoms. This proactive approach, the Hankyoreh argues, is essential for ensuring the health and well-being of women during a significant third of their lives.

This perspective is particularly relevant in South Korea, where societal expectations and the aging population necessitate a focus on healthy aging for women. The article implicitly calls for a more nuanced public discourse, moving beyond fear-mongering to evidence-based understanding. It empowers women to make informed decisions about their health, recognizing that the benefits of HRT, when managed appropriately, can far outweigh the perceived risks, especially in the crucial early menopausal years.